Drug Profile
LF 801
Latest Information Update: 30 Mar 2001
Price :
$50
*
At a glance
- Originator Groupe Fournier
- Class
- Mechanism of Action Bradykinin B2 receptor antagonists; Mast cell inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 30 Mar 2001 Discontinued-Preclinical for Asthma in France (Unknown route)
- 08 Feb 2000 LF 801 is available for licensing (m.hubert@fournier.fr)
- 18 Nov 1999 Preclinical development for Asthma in France (Unknown route)